CD274 and plasma cell myeloma: These findings suggest that the upregulation of PD‐L1 expression induced by chemotherapy enhances the sensitivity of myeloma cells to PD‐L1 antibody therapy, which has important implications for the clinical application of PD‐L1 antibodies.